Form 4: Arteris CEO Charles Janac Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan
SEC Form 4 Filing
Arteris CEO Charles Janac sold a total of 3,303 shares of common stock on December 3rd and 4th, 2024, to cover tax liabilities and under a pre-arranged trading plan.
Summary
- Arteris, Inc. CEO Charles Janac sold 1,242 shares of common stock on December 3, 2024, at an average price of $8.5783 per share.
- He also sold 2,061 shares on December 4, 2024, at a weighted average price of $8.8871 per share.
- These transactions were made to cover tax liabilities arising from the release of restricted stock units and under a 10b5-1 trading plan adopted on February 27, 2024.
- Following these sales, Janac directly owns 274,776 shares of Arteris common stock.
- He also indirectly owns 10,307,691 shares through Bayview Legacy, LLC and 63,252 shares through the Charles & Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity, which is neither positive nor negative for the company's overall prospects. The sales are explained by tax obligations and a pre-arranged trading plan.
Industry Context
This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, such as those in the semiconductor and technology sectors, to manage their stock sales while avoiding insider trading concerns.
- Similar filings are regularly seen from executives at companies like ARM Holdings, Synopsys, and Cadence Design Systems, where stock-based compensation is a significant part of executive pay.
- The volume of shares sold by Janac is relatively small compared to the total shares he controls, which is typical for executives managing their personal finances and tax obligations.
Stakeholder Impact
- The stock sales by the CEO may have a minor impact on the stock price, but the transactions are not indicative of any change in the company's fundamentals.
- Shareholders may view the sales as routine and not a cause for concern, given the pre-arranged trading plan and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 2024-02-27 | Date the 10b5-1 trading plan was adopted by Charles Janac. |
| 2024-12-03 | Date of the first stock sale of 1,242 shares at an average price of $8.5783. |
| 2024-12-04 | Date of the second stock sale of 2,061 shares at a weighted average price of $8.8871. |
Keywords
Arteris, Charles Janac, insider trading, stock sale, Form 4, 10b5-1 plan, executive compensation, share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.